EyeNet - American Academy of Ophthalmology

Advertisement
EyeNet Magazine /

Latest Issue

March 2021
Download PDF

Holistic Care for Chronic Eye Conditions

Beyond exams and tests: This month’s feature takes a deeper look at how disease and treatment affect patients’ lives.

The March supplement from Regeneron Pharmaceuticals can be found here: Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion.

Ophthalmic Pearls

Manual Small-Incision Cataract Surgery in Pseudoexfoliation Syndrome

Written By: Stephen Lau, MBChB, Allison Jarstad, DO, David Khorram, MD, and Matt Oliva, MD
Edited By: Bennie H. Jeng, MD

A guide to manual small-incision cataract surgery in patients with pseudoexfoliation, a condition notorious for increasing the risk of intra- and post-op complications. Web Extra: MSICS video.

Comments 0
Views 122

Clinical Update

When There’s No Zonular Support: OTA Update and Case Studies

Written By: Arthur Stone, Contributing Writer, interviewing Nicole R. Fram, MD, Soosan Jacob, MS, FRCS, DNB, Gregory S.H. Ogawa, MD, and Joanne F. Shen, MD

IOL implantation in the absence of zonular support: A look at the Academy’s updated OTA—plus four case studies. Web Extra: An additional case.

Comments 0
Views 113

Ocular Trauma and Guns: The Need for Data

Written By: Lori Baker-Schena, MBA, EdD, Contributing Writer, interviewing Alexander M. Garrett, MD, Gary N. Holland, MD, Pradeep S. Prasad, MD, MBA, Prem S. Subramanian, MD, PhD, Joseph T. Wertz, AB, and Albert Y. Wu, MD, PhD

Ocular trauma related to gun violence: The need for concrete data on outcomes. Web Extra: Training the next generation of physicians.

Comments 0
Views 193

Morning Rounds

Weighed Down by an Anchor

Written By: Roger P. Harrie, MD
Edited By: Ahmad A. Aref, MD, MBA

Several doctors had told the 78-year-old that his vision loss was due to “a blood clot in the eye.” What’s your diagnosis?

Comments 0
Views 81

Blink

Can You Guess March's Mystery Condition?

Make your diagnosis in the comments, and get the answer to last month’s mystery.

Comments 0
Views 265

Journal Highlights

Deep Learning to Predict Glaucomatous Changes, a New WHO System to Classify Conjunctival Lesions, and More

Our editors summarize the most exciting studies from Ophthalmology, Ophthalmology Retina, American Journal of Ophthalmology, JAMA Ophthalmology, and other journals.

Comments 0
Views 75

News in Review

Aflibercept Versus Surgery for Vitreous Hemorrhages

Proliferative DR: Aflibercept versus PRP.

Comments 0
Views 133

Using OCT and OCTA to Detect Parkinson

Researchers identify several potential retinal and choroidal biomarkers for the diagnosis of Parkinson disease.

Comments 0
Views 84

Comparing CXL Protocols

CXL for corneal ectasia.

Comments 0
Views 64

Zika’s Impact After Birth

Animal study sheds light on ocular defects following Zika virus infection.

Comments 0
Views 33

Academy Notebook

News, Tips, Resources

Virtual recognition for LDP XXII, class of 2020. A unique opportunity to attend Mid-Year Forum 2021. And more.

Comments 0
Views 29

Practice Perfect

Turning His Brown Eyes Blue: A Patient’s Hazardous Goal

Written By: Jake E. Radell and Joseph F. Panarelli, MD
Additional Commentary By: Ron W. Pelton, MD, PhD

It seemed that nothing could deter this patient from pursuing unapproved and unsafe treatments to lighten his irises. A case study and commentary.

Comments 0
Views 334

Savvy Coder

Exams That Don’t Take Place in the Office (Tip: The New E/M Guidelines Don’t Apply)

Written By: Sue Vicchrilli, COT, OCS, OCSR, and Anthony P. Johnson, MD, FACS, OCS

When you provide an evaluation and management (E/M) service in a nonoffice setting, you should still use the 1997 rules.

Comments 0
Views 186

Opinion

Resilience, Self-Care, and Running the Long Race

Ruth D. Williams, MD, Chief Medical Editor, on adapting well during the COVID marathon.

Comments 0
Views 132

Current Perspective

Ophthalmology and Remote Work

David W. Parke II, MD, Academy CEO, on the changing scope of ophthalmologic “work.”

Comments 0
Views 133

Letters

Thoughts From Your Colleagues

Working with industry during COVID. An additional perspective on giant cell arteritis. Make 2021 your year of advocacy.

Comments 0
Views 8